Virpax Accounts Payable from 2010 to 2024

VRPX Stock  USD 0.45  0.01  2.17%   
Virpax Pharmaceuticals Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to 17.54 in 2024. Accounts Payable is the amount Virpax Pharmaceuticals owes to suppliers or vendors for products or services received but not yet paid for. It represents Virpax Pharmaceuticals' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-12-31
Previous Quarter
75.4 K
Current Value
2.4 M
Quarterly Volatility
1.4 M
 
Covid
Check Virpax Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Virpax Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 988 or Interest Expense of 126.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.03. Virpax financial statements analysis is a perfect complement when working with Virpax Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Virpax Pharmaceuticals Correlation against competitors.
For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.

Latest Virpax Pharmaceuticals' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Virpax Pharmaceuticals over the last few years. An accounting item on the balance sheet that represents Virpax Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Virpax Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Virpax Pharmaceuticals' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Virpax Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Pretty Stable
   Accounts Payable   
       Timeline  

Virpax Accounts Payable Regression Statistics

Arithmetic Mean9,241
Geometric Mean2,370
Coefficient Of Variation108.42
Mean Deviation6,916
Median6,553
Standard Deviation10,018
Sample Variance100.4M
Range37.6K
R-Value0.25
Mean Square Error101.3M
R-Squared0.06
Significance0.37
Slope561.48
Total Sum of Squares1.4B

Virpax Accounts Payable History

2024 17.54
2023 18.46
202237.6 K
202119.8 K
202022.1 K
2019 3.5

About Virpax Pharmaceuticals Financial Statements

Virpax Pharmaceuticals investors use historical fundamental indicators, such as Virpax Pharmaceuticals' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Virpax Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable 18.46  17.54 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Virpax Stock Analysis

When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.